Lifecycle Governance Agency
Operational governance for clinical AI and robotics
We help healthcare institutions and technology providers establish documented ownership, human oversight, deployment evidence and continuous lifecycle review.
For health systems, care organisations & clinical AI providers
[ The Primary Engagement ]
Governance Compliance Programme
A structured implementation programme for healthcare institutions seeking demonstrable control over clinical AI and robotics—from system discovery and role mapping to accountability, human oversight, evidence management and continuing review.
01
Discover & Classify
- —AI and robotics inventory
- —Intended-use review
- —Preliminary EU AI Act role and risk mapping
- —Provider and deployer responsibility mapping
Deliverable
Verified System Inventory and Governance Baseline
02
Assign & Implement
- —Institutional ownership
- —Human-oversight responsibilities
- —Escalation and incident pathways
- —Governance control implementation
Deliverable
Accountability and Control Framework
03
Record & Review
- —Clinical AI Registry™ record
- —Version and change history
- —Incident and review records
- —Monitoring responsibilities
- —Periodic continuation, restriction or retirement decision
Deliverable
Operational Governance Record and Review Cycle
[ The Governance Mandate ]
From Static Compliance to Continuous Institutional Oversight
LGA supports operational governance through two connected institutional functions:
The Evidence Infrastructure
Clinical AI Registry™
Clinical AI Registry™ provides a structured institutional record for documenting deployed clinical AI and robotics, their intended use, accountable owners, oversight arrangements, evidence status, versions, incidents and review decisions.
The Registry supports governance evidence, institutional review and audit readiness. It does not replace regulatory conformity assessment, a notified body, legal advice or the provider's statutory quality-management and post-market-monitoring obligations.
Function II — The Oversight
Governance Review
Continuing Oversight & Review
Governance review processes established, responsibilities assigned and evidence records activated for the agreed systems in scope. A continuing institutional review function that supports the evidence interface between provider monitoring responsibilities and deployer oversight.
Performance
Change & Drift
Incidents
Governance Status
[ Institutional Risk ]
Where Health Systems & Care Organisations Are Exposed Today
Visibility
No central AI system registry.
Clinical AI systems are deployed without a unified inventory, leaving governance teams blind to what is operating and where.
Accountability
No defined ownership of AI-driven decisions.
When an AI system influences a clinical outcome, no single person or function bears documented accountability.
Compliance
No risk classification under the EU AI Act.
Providers of high-risk AI systems must follow the applicable conformity-assessment route before placing the system on the market or putting it into service.
Audit-Ready
No continuous documentation for regulatory review.
Fragmented or outdated records can make it difficult for providers and deploying institutions to demonstrate how responsibilities, controls and lifecycle decisions are being maintained.
[ Institutional Case Study ]
From Undocumented AI to a Demonstrable Governance Record
A high-level account of how a European health system established documented ownership, human oversight and continuing lifecycle review for its clinical AI—using the Governance Compliance Programme and the Clinical AI Registry™.
Starting Position
- —A multi-site European health system operating radiology, oncology and intensive-care AI decision-support tools.
- —No unified inventory of deployed clinical AI; oversight responsibilities undocumented; audit evidence fragmented across departments.
- —Regulatory pressure under the EU AI Act and internal audit findings prompted a board-level mandate for demonstrable governance.
Process Applied
Discover & Classify
A verified inventory of deployed clinical AI was established. Each system was mapped to intended use, clinical department and a preliminary EU AI Act risk classification.
Assign & Implement
Accountable clinical, governance and technical owners were named per system. Human-oversight and escalation pathways were documented and embedded into operational workflows.
Record & Review
Each system was entered into the Clinical AI Registry™ with version history, evidence bundles and a defined review cycle, creating a continuous lifecycle record.
Governance Outcomes
100%
Deployed clinical AI systems registered with accountable owners
3
Clinical departments brought under a unified governance record
Defined
Human-oversight and escalation pathways per system
Audit-ready
Evidence framework established for continuing review
Illustrative composite based on the Lifecycle Governance Agency programme methodology. Outcomes reflect process and evidence-framework adoption, not clinical performance claims.
Evidence Frameworks Established
System Inventory & Classification
Intended-use statements, deployment context and EU AI Act role/risk mapping held in a single registry record.
Accountability & Oversight Map
Named owners, human-oversight arrangements and escalation pathways documented and reviewable at board level.
Evidence Bundles
Vendor documentation, validation evidence and procurement records consolidated against each registered system.
Continuing Review Record
Monitoring events, incidents and periodic review decisions captured to support audit readiness over the lifecycle.
China Desk
China–Europe Clinical AI Governance Corridor
The China–Europe Clinical AI Governance Corridor supports structured readiness and deployment planning for Chinese clinical AI and robotics entering European institutional settings. It connects manufacturer evidence, European operator responsibilities, data and cybersecurity questions, human oversight and continuing lifecycle governance.
The Shenzhen Bridge functions as the corridor's geographical and relationship node — not a separate commercial product.
Manufacturer Readiness
Assessment of intended use, evidence, system architecture and governance gaps.
European Deployment
Role mapping, institutional requirements, human oversight and deployment planning.
Data & Remote Access
Data location, cybersecurity, software updates and remote-access responsibilities.
Lifecycle Accountability
Version changes, incidents, monitoring responsibilities and institutional review.
China–Europe Clinical AI Governance Corridor
The Corridor does not guarantee regulatory approval, procurement eligibility or hospital adoption.
Robotics · Embodied AI
Robotics Governance
A specialist application of the Governance Compliance Programme for embodied AI, surgical systems, rehabilitation robotics, autonomous care platforms and other physical systems operating alongside patients and professionals.
Operational boundaries
Human intervention
Override authority
Remote access
Software and hardware changes
Incident escalation and decommissioning
Robotics Governance Programme
The robotics-specific implementation route within the Governance Compliance Programme.
[ Implementation ]
Typical Implementation — 90 Days
Achieve operational governance and continuing review within one quarter.
Discovery & Registration
AI system discovery and registration in the Clinical AI Registry™.
Classification & Accountability
EU AI Act risk classification and accountability mapping. Systems requiring provider conformity-assessment evidence are identified and documented.
Governance Review Activation
Governance review processes established, responsibilities assigned and evidence records activated for systems in scope.
Founder — Lifecycle Governance Agency
Founder
Dr Rebindrenath R. Goerdin
Physician · Founder — Lifecycle Governance Agency
A physician and healthcare entrepreneur working at the intersection of clinical medicine, digital health infrastructure, and governance frameworks for artificial intelligence in healthcare — establishing operational oversight for AI and robotics across European health systems.